.CVSHealth will settle with Florida over allegations related to opioid prescriptions, the company announced Wednesday.
The $484 million settlement will resolve CVS's role in an opioid lawsuit that will begin in April and is part of a larger settlement that will help Florida combat the growing use of opioids in the United States."Putting these claims behind us is in the best interest of all parties and helps sharpen our focus on delivering a personalized, connected health care experience for the millions of consumers who rely on us," CVS Health executive Thomas Moriarty said in a press statement.
"The [money] secured from CVS, Teva, Allergan and Endo will help further our efforts to remediate the harm and suffering of Floridians," Moody said in a press statement.The settlement with Florida does not include any admission of wrongdoing, according to CVS. While CVS, Allergan, and Teva are no longer facing Florida's class-action lawsuit, several other medical companies and at least one pharmacy will face scrutiny when the trial begins next month. The 2018 lawsuit names Purdue Pharmaceuticals, Walgreens, Johnson & Johnson, and several others as playing a significant role in the opioid crisis.